ELOC and nonpapillary renal cell carcinoma: TCEB1-mutated tumors also did not possess any additional recurrent copy number events such as 5q amplifications or 14q or 9p losses which are common in ccRCC, papillary renal cell carcinoma (PRCC), and collecting duct carcinoma (CDC) (3, 13).